Xiuqin Li

581 total citations
14 papers, 432 citations indexed

About

Xiuqin Li is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Xiuqin Li has authored 14 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Biotechnology. Recurrent topics in Xiuqin Li's work include Virus-based gene therapy research (3 papers), Cancer Research and Treatments (3 papers) and Cancer-related Molecular Pathways (3 papers). Xiuqin Li is often cited by papers focused on Virus-based gene therapy research (3 papers), Cancer Research and Treatments (3 papers) and Cancer-related Molecular Pathways (3 papers). Xiuqin Li collaborates with scholars based in China, Hong Kong and United States. Xiuqin Li's co-authors include Yu Xia, Longjiang Li, Lois A. Chandler, Weiwei Zhang, Wei Li, Dinggang Li, Aiguo Patrick Hu, Wei Xu, Michael J. Zhang and Dominic Man-Kit Lam and has published in prestigious journals such as Cancer Letters, Clinical Nutrition and Human Gene Therapy.

In The Last Decade

Xiuqin Li

13 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuqin Li China 9 243 154 138 65 54 14 432
R C Pong United States 9 359 1.5× 243 1.6× 329 2.4× 40 0.6× 45 0.8× 9 593
Ramon U. Jin United States 12 273 1.1× 123 0.8× 78 0.6× 71 1.1× 11 0.2× 26 570
Lu-Zhe Pan Canada 5 245 1.0× 332 2.2× 127 0.9× 184 2.8× 58 1.1× 5 562
Liting You China 9 182 0.7× 152 1.0× 35 0.3× 65 1.0× 11 0.2× 25 412
Christopher Taylor United States 3 156 0.6× 179 1.2× 69 0.5× 58 0.9× 41 0.8× 6 494
Ahuva Kapon Israel 6 251 1.0× 199 1.3× 49 0.4× 37 0.6× 56 1.0× 8 383
Andrea Warlters Australia 8 178 0.7× 161 1.0× 93 0.7× 57 0.9× 10 0.2× 9 410
James A. Zanghi United States 10 441 1.8× 70 0.5× 76 0.6× 53 0.8× 28 0.5× 16 578
Ruizhan Tong China 11 211 0.9× 203 1.3× 40 0.3× 75 1.2× 10 0.2× 20 450
Morris Laster Israel 8 353 1.5× 40 0.3× 135 1.0× 109 1.7× 75 1.4× 10 463

Countries citing papers authored by Xiuqin Li

Since Specialization
Citations

This map shows the geographic impact of Xiuqin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuqin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuqin Li more than expected).

Fields of papers citing papers by Xiuqin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuqin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuqin Li. The network helps show where Xiuqin Li may publish in the future.

Co-authorship network of co-authors of Xiuqin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuqin Li. A scholar is included among the top collaborators of Xiuqin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuqin Li. Xiuqin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yin, Nan, Zhipeng Tang, Yanyan Yang, et al.. (2025). EGb761 suppressed vascular dementia via modulating Wnt/β-catenin signaling pathway-induced apoptosis and autophagy in hippocampal neuronal cells. European journal of medical research. 30(1). 497–497.
2.
Liu, Chuan, Fang-Hua Liu, Yifan Wei, et al.. (2021). Association between pre-diagnostic dietary pattern and survival of ovarian cancer: Evidence from a prospective cohort study. Clinical Nutrition. 41(2). 452–459. 28 indexed citations
3.
Li, Yi, Wei Guo, Xiuqin Li, et al.. (2021). Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers. International Journal of Oral Science. 13(1). 38–38. 18 indexed citations
4.
Xia, Yu, Lei Wang, Xiaolin Ma, & Xiuqin Li. (2020). Investigation on the Genomic Characterization of Uterine Sarcoma for rAd- p53 Combined with Chemotherapy Treatment. Human Gene Therapy. 31(15-16). 881–890. 5 indexed citations
5.
Xia, Yu, Xiuqin Li, & Wei Sun. (2020). Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China. Current Gene Therapy. 20(2). 127–141. 33 indexed citations
6.
Qu, Hui, Yu Xia, & Xiuqin Li. (2020). Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer. Current Gene Therapy. 20(4). 313–320. 6 indexed citations
7.
Wang, Lei, et al.. (2020). Rapamycin alleviates cognitive impairment in murine vascular dementia: The enhancement of mitophagy by PI3K/AKT/mTOR axis. Tissue and Cell. 69. 101481–101481. 39 indexed citations
8.
Wang, Lei & Xiuqin Li. (2020). Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis. Oncology Reports. 43(6). 1755–1770. 26 indexed citations
9.
Zhong, Fangfang, Tao Zhu, Xuedong Pan, et al.. (2019). Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53. Cancer Medicine. 8(8). 3928–3935. 7 indexed citations
10.
Zhang, Weiwei, Longjiang Li, Dinggang Li, et al.. (2018). The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic. Human Gene Therapy. 29(2). 160–179. 220 indexed citations
11.
Xia, Yu, Zhenhua Du, Xinyan Wang, & Xiuqin Li. (2017). Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy. Human Gene Therapy. 29(2). 242–250. 21 indexed citations
12.
Li, Xiuqin, et al.. (2016). Regulatory role of microRNA-30b and plasminogen activator inhibitor-1 in the pathogenesis of cognitive impairment. Experimental and Therapeutic Medicine. 11(5). 1993–1998. 9 indexed citations
13.
Li, Xiuqin, Bo Ren, & Zhenhua Du. (2008). Effect of activin A on OVCAR-3 Ovarian epithelial cancer cells. Chinese Journal of Cancer Research. 20(3). 186–189. 2 indexed citations
14.
Li, Xiuqin, et al.. (2008). Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma. Cancer Letters. 275(1). 109–116. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026